Category Archives: Clinical Cardiology

"Over the last couple of years, management at RUMC has made real progress in growing the physician base," Klein said. Continue reading →

Axillary vein puncture guided by ultrasound, using a readily learned technique, was superior to cephalic vein dissection via cut-down for implantation of cardiac device leads in a small, multicenter, randomized clinical trial from Brazil. Use of the axillary vein provided better success with shorter procedure time. In a comparison of the two approaches for pacemaker or defibrillator implantations, "the success rate...was significantly higher in the axillary group, 97.7% vs 54.5%" for the cephalic group, lead author Ana Paula Tagliari, MD, MSc, Hospital de Clinicas de Porto Alegre, said in March at an online presentation for the virtual congress of the European Heart Rhythm Association (EHRA) 2020. Continue reading →

Text Size: A- A+ I am a physician and a scientistat the University of Virginia. I care for patients and conduct research to find better ways to diagnose and treat infectious diseases, including COVID-19 Continue reading →

Global Cardiology EMR Software Market Research Report 2020 accountable for its research which provides a top to bottom evaluation of this market so far as sales and developing business sector. The Cardiology EMR Software report comprises business overview, product offering, revenue share, strategies, and service offering of these prominent players. This report covers several vital regions from the global Cardiology EMR Software industry. Continue reading →

July 03, 2020 With the upcoming school year seven weeks away, it is time to recognize that no matter what the classroom and the class schedule may look like, completion of the immunization requirements is still going to be in force. Besides the battery of vaccinations due upon entry to school, there is a requirement for children entering the seventh grade, or age 12, to receive their second meningococcal vaccine. A plan had been developed between school officials, school nurses and this department to hold immunization events at the end of the school year and summer to ensure that this population received their immunization. Continue reading →

The DAPA-HF trial has already changed cardiology in opening up a new class of drugs to patients with heart failure (HF), whether or not they have diabetes. Now the trial is yielding clues as to how it benefits them Continue reading →

Researchers have used an optical mapping system to observe how the malaria drug hydroxychloroquine, which has been touted as a possible treatment for COVID-19, creates disturbances in heart rhythm in an animal model. The research, published in the journal Heart Rhythm, found that the drug made it surprisingly easy to trigger arrhythmias in two types of animal hearts by altering the timing of electrical waves that control heartbeat. We have illustrated experimentally how the drug actually changes the waves in the heart, and how that can initiate an arrhythmia, said Flavio Fenton, a professor in the School of Physics at the Georgia Institute of Technology (Atlanta, USA) and the papers corresponding author Continue reading →

Cardiology information system (CIS) works mainly on the similar lines of radiology PACS; however, it primarily focuses on the retrieval of cardiology-centric images. The most common clinical benefit that cardiology information system provides is the ability for cardiologists and the staff to carry out their daily duties from one system. A successfully implemented CIS solution enables organizations to update and enhance the cardiovascular service line in a healthcare set up. Continue reading →

June 11, 2020 04:00 ET | Source: Royal Philips photo-release June 11, 2020 Amsterdam, the Netherlands Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced thatits Lumify with Reacts handheld tele-ultrasound solution is now commercially available in Japan. Continue reading →

New observational data from Wuhan, China, suggest that hypertensive patients hospitalized with COVID-19 had a twofold increased risk of dying compared to those without hypertension, and that not being on medication for hypertension at the time of hospitalization worsens outcomes. The study also provides additional reassurance about the use of antihypertensives that target the renin-angiotensin-aldosterone system (RAAS). Patients with RAAS inhibitors were not exposed to a higher risk of mortality in our study and, after pooling previously published data in a study-level meta-analysis, the use of RAAS inhibitors was shown to be possibly associated with lower risk of mortality, write Chao Gao, MD (Xijing Hospital, Xian, China), and colleagues. Continue reading →